The regulations introduce several key definitions that structure compliance obligations. "Donor" is simply the person in relation to whom an order is made a person from whom a sample is required by a court order under section 13 of the Act. "Sampler" is a person referred to in regulation 6 who takes a bodily sample; that person must be either a medical practitioner or someone employed by a hospital, pathology practice, parentage testing practice or medical practitioner for the purpose of taking samples. This is not a wide class; it excludes, for example, a nurse employed by a general practice who does not have a specific role in sample taking, unless the practice has designated that role. "Bodily sample" is defined broadly and includes but is not limited to blood, allowing for buccal swabs, hair roots and skin scrapings under regulation 9. "Child" means a person under 18, and "parent" is defined expansively to include anyone with parental responsibility, a guardian, a foster parent, or someone who has generally acted in place of a parent for a significant length of time. This broad definition acknowledges that the donor child may not be living with biological parents and that the person giving consent on the child's behalf must have genuine care responsibilities. "Guardian" similarly covers formal appointees under state laws as well as persons responsible for long-term care, welfare and development. "Laboratory" must be accredited by NATA for parentage testing procedures, which outsources quality assurance to a private accreditor. The prescribed procedures under regulation 4 are red cell antigen blood grouping, red cell enzyme blood grouping, HLA tissue typing, testing for serum markers, and DNA typing. Notably, DNA typing is the only procedure without a fixed statutory time limit for completion, which reflects the variable complexity of DNA analysis. "Gender identity" is defined in regulation 10(6) for labelling purposes as the person's gender-related identity, appearance or mannerisms, with or without regard to designated sex at birth, which is a pragmatic inclusion for sample identification rather than a substantive legal concept. The forms in Schedule 1 are incorporated by reference; while they are not reproduced in text in the legislative instrument, they are integral to compliance because a report not in Form 3 is of no effect.

The regulations directly affect several distinct groups. First, donors individuals who are subject to a court order for parentage testing under section 13 of the Act. These are typically adults and children involved in disputes about biological parentage, whether in family law proceedings, child support matters or inheritance claims. For adult donors, the regulations impose personal obligations to complete an affidavit and provide a photograph before a sample can be taken. For child donors, the obligations fall on the child's parent as defined broadly: a person with parental responsibility, a guardian, a foster parent or a long-term caregiver. That parent must complete the affidavit on the child's behalf and sign the sample container label instead of the child. For donors with a disability that prevents them making reasonable judgments about their personal circumstances, a guardian must act in their place. Second, samplers the medical practitioners and hospital or pathology employees who physically take the sample. They must ensure they are qualified, use sterile disposable equipment, witness the affidavit completion before sampling, and complete detailed paperwork afterward. Failure to comply exposes them to potential professional disciplinary action or evidentiary exclusion of the sample. Third, laboratories that perform the testing must be NATA-accredited for parentage testing and must comply with specific turnaround times and report in the prescribed form. A laboratory that issues a non-compliant report renders that report void, which could have significant consequences in litigation. Fourth, the legal system: courts that make orders under the Act rely on the regulations to ensure the integrity of testing. The parties to proceedings also bear the cost of compliance, including fees for sample collection, documentation, transport and laboratory testing. Fifth, overseas courts and parties in New Zealand and the United Kingdom are affected because orders from those jurisdictions are recognised as "prescribed courts" under the Act, meaning that a parentage testing order from a New Zealand or UK court may be enforceable in Victoria or may allow evidence from those jurisdictions to be used. Finally, the regulations affect NATA itself as the designated accreditation body, though the regulations do not impose duties on NATA.

The regulations impose a series of explicit duties on samplers, donors, parents, guardians and laboratories, but they confer relatively few rights. The most significant duty is on the sampler under regulation 6: they must not take a bodily sample unless they are a medical practitioner or an employee of a hospital, pathology practice, parentage testing practice or medical practitioner acting for that purpose. This restriction limits the pool of people who can perform the collection and creates a de facto requirement that the collection occur in a clinical or practice setting rather than, say, a police station or a home. Regulation 7 imposes a duty on the donor (or their parent or guardian) to complete an affidavit in Form 1 and attach a recent photograph before the sample is taken. The sampler must not take the sample unless that affidavit has been completed. That duty effectively gives the sampler a right to see the completed affidavit and photograph before proceeding, and a corresponding right to refuse to take the sample if the documentation is incomplete or the photograph does not meet the 45 mm by 35 mm full-face specification. Regulation 8 imposes duties on samplers regarding blood collection: they must use a previously unused, sterile, disposable needle and syringe and must clean the skin with antiseptic. Regulation 9 imposes similar duties for DNA typing using swabs or implements for skin scrapings or hair roots: the swab or implement must be unused and sterile. Regulation 10 imposes detailed duties on samplers after collection: they must place the sample immediately in a new, unused container that is tamper-evident, label it in ink with the donor's full name, date of birth, gender identity, collection date and time, and have the label signed by both the sampler and the donor (or parent or guardian for a child or disabled donor). The sealing and labelling must occur in the presence of the donor, or if the donor is a child or disabled person, in the presence of a parent or guardian. This duty gives the donor or their representative a right to be present during the sealing and signing, which is a rare procedural safeguard. Regulation 11 requires the sampler to complete a Form 2 statement as soon as practicable and to affix the donor's photograph across the statement with a signature partly on the photograph and partly on the statement, so that any later removal would be evident. Regulation 12 requires the sampler to pack and store the sample to preserve its integrity and to send the affidavit and statement to the laboratory with the sample. Regulation 13 imposes duties on laboratories: they must test in accordance with NATA-accreditation standards and within the specified timeframes. Regulation 14 requires the laboratory to produce a report in Form 3; a non-compliant report has no effect, which operates as a de facto right of the parties to challenge any report that deviates from the form.

The regulations themselves do not create specific penalty provisions or monetary fines. Instead, enforcement operates through several indirect but potent mechanisms. The most significant is regulation 14(2): a report not completed in accordance with Form 3 in Schedule 1 is of no effect. This means that if a laboratory issues a parentage testing report that does not follow the prescribed form, the report cannot be tendered as evidence in proceedings under the Act. The consequence is that the parties must either obtain a compliant report or risk having no admissible testing evidence at all. That can derail a case or lead to additional costs for re-testing. The regulation does not specify what deviations are fatal, but any departure from the form creates litigation risk. Second, the requirement that a sampler must be a medical practitioner or a specifically employed person under regulation 6 creates a de facto prohibition on unqualified persons taking samples. If a sample is taken by someone outside that class, the sample may be considered tainted and evidence derived from it may be excluded by the court. The Act itself provides the enforcement framework: section 13 of the Act allows a court to order a person to submit to a parentage testing procedure, and failure to comply with such an order can lead to contempt proceedings or adverse inferences being drawn. The regulations do not add to those powers, but they define the procedure that must be followed if the order is to be carried out in a way that yields admissible evidence. Third, professional misconduct or negligence by a sampler who fails to follow the regulations could result in civil liability, disciplinary proceedings before the Medical Board of Australia, or adverse findings in family law proceedings. Fourth, laboratories that breach testing timeframes or accreditation standards risk losing NATA accreditation or facing contractual liability. There is no explicit criminal penalty in the regulations, but the practical sanctions evidentiary exclusion, reputational damage, and potential civil action are substantial. The regulation of overseas jurisdictions under regulation 15 has no penalty element but ensures that testing orders from New Zealand and the United Kingdom may be recognised, which indirectly affects enforcement of parentage testing obligations across borders.

The regulations sit beneath the Status of Children Act 1974 and derive their authority from it. Section 11 of the Act gives the Governor in Council power to prescribe medical procedures for parentage testing, which regulation 4 does. Section 17(1) of the Act requires any report of results to be in the prescribed form, which regulation 14 and Form 3 provide. The regulations therefore fill in the procedural gaps left by the Act. They also interact with the Family Law Act 1975 (Cth) insofar as parentage testing orders may be sought in federal family law proceedings, and the Victorian regulations may influence the evidentiary weight given to testing conducted in this state. The Evidence Act 2008 (Vic) governs the admissibility of reports and affidavits, and the regulations strict chain-of-custody and identity verification requirements are designed to meet the standards of reliability and authenticity that courts expect. A sample collected without following the regulations may be challenged under the Evidence Act as unreliable or prejudicial. The regulations also interact with the Health Records Act 2001 (Vic) regarding the handling of health information including genetic information, though the regulations do not explicitly reference that Act. The definition of "guardian" in regulation 3 incorporates appointments under state laws, the laws of other states and territories, which means interaction with guardianship legislation across Australia. For child donors, the broad definition of "parent" including foster parents and long-term carers interacts with the Children, Youth and Families Act 2005 (Vic) and the Family Law Act regarding who may consent to medical procedures. The requirement that laboratories be accredited by NATA interacts with NATA's own standards and procedures, which are private contractual arrangements but effectively mandated by state regulation. Finally, regulation 15's prescription of New Zealand and the United Kingdom as overseas jurisdictions for the definition of "prescribed court" interacts with the Trans-Tasman Proceedings Act 2010 (Cth) and mutual recognition arrangements with the UK. Overseas court orders for parentage testing may be enforceable in Victoria under the Act, and evidence from testing conducted in those jurisdictions may be admissible if the procedures are substantially equivalent.

Based on the text of the Status of Children (Parentage Testing) Regulations 2017 as provided, the instrument was notified in the Victoria Government Gazette on 21 June 2017 and took effect on 28 June 2017. It is displayed and numbered in accordance with the Rules Publication Act 1953. The text shown is the version in force as at 12 April 2026, suggesting that no amendments have been made to the regulations between their commencement and that date. However, the absence of repealed or inserted provisions in the supplied text does not conclusively prove that no amendments exist; it is possible that minor technical amendments have been made but are not reflected in the extract provided. The regulations are relatively short and deal with a narrow area of practice, so amendment activity may be infrequent. The parent Act, the Status of Children Act 1974, has been amended several times over its long life, but the regulations appear to have remained static since 2017. Practitioners should always verify the current version with the Victorian legislation website before relying on the text, especially if they are preparing for litigation. The regulations do not contain any transitional provisions or savings provisions, which means that any future amendment would apply prospectively unless otherwise stated. The forms in Schedule 1 are likely to be updated from time to time to reflect changes in administrative practice or technology, but the current forms remain in force. The definition of "gender identity" was inserted at the time of making, reflecting a relatively progressive stance for 2017, and may not have been present in earlier drafts.

The regulations themselves have not been the subject of reported litigation in the Victorian courts, according to the source provided. No cases are cited in the text. However, the regulations are likely to have been considered in the context of parentage disputes, particularly where the admissibility of test results was challenged on procedural grounds. The most likely area of litigation concerns regulation 14(2) and what constitutes a report "completed in accordance with" Form 3. Courts may be required to determine whether a minor deviation from the form whether a missing field, an incorrect font, or an electronic signature renders the report of no effect. There may also be disputes about whether the sampler was qualified under regulation 6, particularly if the sample was taken by a nurse who was not employed for the specific purpose of taking bodily samples under the regulations. The definition of "parent" for a child donor could be litigated if a person claiming to be a parent under the broad definition completes the affidavit but their standing is contested by another party. The photograph requirements under regulation 7 the size, full-face, plain background, and signature across photograph and statement in regulation 11 could also be the subject of evidentiary challenges if a party alleges the photograph does not accurately identify the donor. Because the regulations create a strict path, any deviation provides an opportunity for a party to argue that the test results should be excluded. The absence of reported cases may simply indicate that compliance is generally achieved, or that parties settle rather than litigate procedural defects. Practitioners should be aware that the regulations have been in force since 2017 and that any parentage testing conducted in reliance on them should be scrutinised for full compliance to avoid costly court challenges.

Several provisions contain traps that can render testing inadmissible or cause significant delay and expense. The most critical gotcha is regulation 14(2): a report not completed in accordance with Form 3 is of no effect. That is an absolute bar, not a presumption. The Form 3 is not reproduced in text in the regulations as provided, but it is a multi-page document requiring specific fields. A failure to include every required field or to use the exact layout may void the report. Second, the photograph under regulation 7 must measure approximately 45 mm by 35 mm and show a full-face view of the donor's head and shoulders against a plain background. A passport-style photo that is slightly larger or has a busy background will technically not comply. The sampler must then affix that photograph to the Form 2 statement and sign partly on the photograph and partly on the statement, so that removal would be evident regulation 11(c). If the sampler signs only on the statement, the chain-of-custody is broken. Third, the affidavit under regulation 7 must be completed by the donor (or parent or guardian) immediately before the sample is taken. An affidavit prepared the day before and brought to the appointment arguably does not comply. The sampler must not take the sample unless the affidavit is completed at that moment. Fourth, the container must be sealed in a way that any subsequent opening would be evident regulation 10(2)(b). This likely requires tamper-evident tape or a sealed bag; a simple screw-cap may not suffice. The label must be written in ink, and the writing must be such that later obscuring, alteration or erasure would be evident. Felt-tip pen that can be smudged may be risky. Fifth, for child donors and disabled donors, the parent or guardian must sign the label instead of the donor, and the sample must be collected in the presence of that parent or guardian. If the parent or guardian leaves the room during collection, that is arguably non-compliance. Sixth, the time limits under regulation 13 are strict for certain procedures: six days for red cell antigen or enzyme grouping or serum markers, three days for HLA tissue typing, and only a "reasonable time" for DNA typing. The laboratory must complete testing within those periods. For dried samples the six-day period can be saved by preparing a dried sample within that time, but that exception does not apply to HLA tissue typing or DNA typing. Seventh, the definitions of "parent" and "guardian" are broad, but a person completing the affidavit must genuinely fall within that definition. A step-parent who has not assumed parental responsibility for a significant length of time may not qualify. Eighth, the sampler must be a medical practitioner or an employee of a hospital, pathology practice, parentage testing practice or medical practitioner for the purpose of taking bodily samples. A phlebotomist at a standalone collection centre who is not employed by a medical practitioner for that purpose may not be permitted to take the sample.

Compliance requires meticulous attention to the sequence and documentation set out in the regulations. The following step-by-step approach minimises risk. First, confirm that a valid court order under section 13 of the Act is in place. The regulations only apply to samples taken under such an order; voluntary parentage testing outside a court order does not need to comply, but the resulting report may not be admissible in court. Second, identify the donor and, if the donor is a child or a person with a disability, identify the appropriate parent or guardian who will act on their behalf. Ensure that the parent or guardian falls within the definitions in regulation 3. Third, obtain a recent photograph of the donor that strictly meets the requirements 45 mm by 35 mm, full-face view of head and shoulders against a plain background. A commercial passport photo service can produce this, but the exact size should be confirmed with a ruler. Fourth, have the donor (or parent or guardian) complete the Form 1 affidavit immediately before the sample is taken. The affidavit must be signed and sworn before an authorised witness (e.g., a justice of the peace) who is independent of the sampling process. The photograph must be attached to the affidavit. Fifth, engage a sampler who is either a medical practitioner or an employee of a hospital, pathology practice, parentage testing practice or medical practitioner, and who is specifically employed for the purpose of taking bodily samples. The sampler should confirm their qualification in writing. Sixth, at the appointment, the sampler must confirm the donor's identity by checking the photograph on the affidavit. The sampler must then clean the skin, use a sterile disposable needle or swab, and take the sample. Seventh, immediately after collection, the sampler must place the sample in a new, unused container that is tamper-evident. The sampler must label the container in permanent ink with the donor's full name, date of birth, gender identity, and the date and time of collection. The label must be signed by the sampler and by the donor (or parent or guardian) in the donor's presence. Eighth, the sampler must complete Form 2 as soon as practicable, affix the donor's additional photograph to it, and sign partly on the photograph and partly on the statement. Ninth, the sampler must pack the sample in a manner that preserves integrity and transport it to a NATA-accredited laboratory, together with the completed affidavit and Form 2 statement. Tenth, the laboratory must perform the testing in accordance with NATA standards and within the time limits in regulation 13. For red cell antigen grouping, enzyme grouping or serum markers, testing must be completed within six days unless a dried sample is prepared within that time. For HLA tissue typing, within three days. For DNA typing, within a reasonable time. Eleventh, the laboratory must issue a report in Form 3 exactly as prescribed. Any departure from the form renders the report void. The report should be checked against the form by a legal practitioner before it is tendered. Finally, all documentation should be retained in case the chain of custody is challenged.